First Patient Dosed in Newest Stage of Study of Pexa-Vec and Chemo as Sold Tumor Fighter
News
The first patient has been dosed in the Phase 2 portion of a clinical trial evaluating a combination of the cancer vaccine Pexa-Vec and chemotherapy in solid tumor patients. The ... Read more